The impact of applying 2019 ATS/ERS quality control standards for spirometry to a large cohort study compared with the 2005 standard

Presented at the Dalhousie/Nova Scotia Health Department of Medicine Research Day 2025.

Previous
Previous

Contemporary Analysis in Pancreatic Enzyme Use in the Nova Scotian Cystic Fibrosis Population

Next
Next

The Social and Economic Burden of Cystic Fibrosis in Canada